Physician

Alexandra Joy Erhardt, D.O.

According to 2025 Medicare claims, Alexandra Erhardt, D.O. (NPI: 1861853343) practices general surgery in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (NPI: 1215989249; TIN: 223376459) and primary practice location at 07601-1997. Erhardt is affiliated with the Houston Methodist Coordinated Care (ACO ID: A3473), participating under the MSSP model.

Erhardt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 151 traditional Medicare patients, billed 485 HCPCS/CPT codes, and received $107,043 in Medicare payments. The top billing code was 50360 (Transplantation of donor kidney). Part D data shows 874 prescription claims across 93 beneficiaries totaling $96,753 in drug costs, led by Valganciclovir Hcl (Valganciclovir Hcl). DME data shows 420 claims. Open Payments data shows 1 records totaling $142. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	20	39	$3,407
2022	54	97	$17,296
2023	55	118	$34,014
2024	151	485	$107,043

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	20	$246
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	21	110	$11,776
2024	93	874	$96,753

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	104	420	$74,495

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
50360	Transplantation of donor kidney	34	34	$1,620
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	76	123	$154
50323	Preparation of donor kidney for transplantation	35	35	$139
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	38	49	$111
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	36	79	$67

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Valganciclovir Hcl	Valganciclovir Hcl	91	2,772	$20,039
Eliquis	Apixaban	19	607	$11,141
Nifedipine Er	Nifedipine	64	2,100	$779
Nystatin	Nystatin	18	540	$698
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	118	3,715	$562

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	14	66	$64,274
J7518	Mycophenolic acid, oral, 180 mg	N	21	84	$6,877
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	28	118	$1,480
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	25	77	$1,449
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	27	$339

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$142	SANOFI-AVENTIS U.S. LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexandra Joy Erhardt, D.O.?

Tedicare shows public-source Medicare data for Alexandra Joy Erhardt, D.O. (NPI 1861853343), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra Joy Erhardt, D.O. have ACO affiliation data?

Alexandra Joy Erhardt, D.O. is shown with ACO affiliation data for Houston Methodist Coordinated Care (MSSP, ACO ID A3473).

What billing organization is linked to Alexandra Joy Erhardt, D.O.?

Alexandra Joy Erhardt, D.O. is linked to HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (billing NPI 1215989249) in the available physician profile data.

Does Alexandra Joy Erhardt, D.O. have Open Payments data?

Alexandra Joy Erhardt, D.O. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.